Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics

INTRODUCTION: Aripiprazole and olanzapine are atypical antipsychotics. Both drugs can induce metabolic changes; however, the metabolic side effects produced by aripiprazole are more benign. The aim of the study was to evaluate if aripiprazole and olanzapine alter prolactin levels, lipid and glucose...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Adv Ther
Main Authors: Koller, Dora, Almenara, Susana, Mejía, Gina, Saiz-Rodríguez, Miriam, Zubiaur, Pablo, Román, Manuel, Ochoa, Dolores, Navares-Gómez, Marcos, Santos-Molina, Elena, Pintos-Sánchez, Elena, Abad-Santos, Francisco
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Healthcare 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7889573/
https://ncbi.nlm.nih.gov/pubmed/33278020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-020-01566-w
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados